Latest filing published 30 Aug 2022 for Unicycive Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Brigitte Schiller: trading record in brief
Brigitte Schiller (board member) discloses dealings in Unicycive Therapeutics, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 16 May 2022 and the latest from 15 July 2022.
Every open-market trade on record is a purchase: 1 purchase worth €12k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 option exercise.
On 30 August 2022 came the latest disclosure, an option exercise in Unicycive Therapeutics, Inc. The latest purchase dates back some time: it was published 1,637 days ago, on 17 May 2022. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Brigitte Schiller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,738 shares0Common StockSEC:0001213900-22-052329:0
- 15,000 shares@ US$0.825100.0% of flowCommon StockSEC:0001213900-22-027501:0Canonical exit: 14 Aug 2022 (T+90)
2 of 2 declarations